Sort
39,280 grants matching “leukemia”
Role of bone marrow Tregs in maintaining stromal cell function
$371,250Robert S Welner · University Of Alabama At Birmingham · R01 · FY2020 · HL
Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia
$371,250Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2023 · CA
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
$371,216Ankur Singh · Cornell University · R33 · FY2017 · CA
The Role of CBFb-MYH11 in Acute Myeloid Leukemia
$371,211James C Mulloy · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · CA
The Role of CBFb-MYH11 in Acute Myeloid Leukemia
$371,211James C Mulloy · Cincinnati Childrens Hosp Med Ctr · R01 · FY2008 · CA
Ty3 viruslike particle morphogenesis and host interactions
$371,191Suzanne Sandmeyer · University Of California-Irvine · R01 · FY2008 · GM
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
$371,168Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2019 · CA
Molecular Recognition during pre-mRNA Splicing
$371,096Clara L Kielkopf · University Of Rochester · R01 · FY2009 · GM
Antitumor-Antibiotics from Marine Microorganisms
$371,070William Fenical · University Of California, San Diego · R37 · FY2006 · CA
T Cell Targeting for GVHD
$371,004Bruce R. Blazar · University Of Minnesota · R01 · FY2008 · HL
Improved Foamy Virus Vectors for AIDS Gene Therapy
$370,977Grant D Trobridge · Washington State University · R01 · FY2015 · AI
Improved Foamy Virus Vectors for AIDS Gene Therapy
$370,977Grant D Trobridge · Washington State University · R01 · FY2016 · AI
Improved Foamy Virus Vectors for AIDS Gene Therapy
$370,977Grant D Trobridge · Washington State University · R01 · FY2017 · AI
Improved Foamy Virus Vectors for AIDS Gene Therapy
$370,977Grant D Trobridge · Washington State University · R01 · FY2014 · AI
Transgenesis and Xenotransplantation
$370,953Jorge A. Piedrahita · North Carolina State University Raleigh · R01 · FY2012 · HL
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS
$370,946City Of Hope/Beckman Research Institute · U10 · FY2003 · CA
Ancillary Studies in Clinical Trials - PRIMeR
$370,927Marcelo C. Pasquini · Medical College Of Wisconsin · R01 · FY2014 · HL
The Molecular Actions of Imatinib Mesylate in GISTs
$370,916Andrew K Godwin · University Of Kansas Medical Center · R01 · FY2011 · CA
USP18 in Cancer Development
$370,916Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · CA
USP18 in Cancer Development
$370,916Dong-Er Zhang · University Of California, San Diego · R01 · FY2023 · CA
Retroviral Subversion of ERAD and Intrinsic Immunity
$370,912Jaquelin Page Dudley · University Of Texas At Austin · R01 · FY2012 · CA
The Role of MLL-AF9 in Acute Myeloid Leukemia
$370,898James C Mulloy · Cincinnati Childrens Hosp Med Ctr · R01 · FY2010 · CA
The Role of MLL-AF9 in Acute Myeloid Leukemia
$370,896James C Mulloy · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · CA
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
$370,892Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Systematic identification of hematopoietic stem cell expansion factors
$370,877Jiwang Zhang · Loyola University Chicago · R01 · FY2020 · HL